CYNARA SCOLYMUS EXTRACT OR A CYNARA SCOLYMUS EXTRACTION FRACTION OR A MIXTURE OF THAT EXTRACT WITH ONE OR MORE OF THESE FRACTIONS OR A MIXTURE OF THESE FRACTIONS, TITLED IN TOTAL CAFEOILQUÍNIC ACIDES, IN TYPICAL CYLINDIC ACIDES, IN EOLYCERIC ACIDES CYNARA SCOLYMUS EXTRACT FRACTION OR MIXTURE OF THAT EXTRACT WITH ONE OR MORE OF THOSE FRACTIONS OR MIXTURE OF THAT FACTIONS FOR USE, CYNARA SCOLYMUS EXTRACT OR CYNARA SCOLYMUS EXTRACTION FRACTION OF MOST REFERRED EXTRACTION OF OTHER REFERRED EXTRACTION MIXING OF THOSE FRACTIONS IN ASSOCIATION WITH ONE OR MORE ANTI-INFLAMMATORY COMPOUNDS AND / OR ANT
The present invention relates to a cynara scolymus titrated extract, to cynara 2/2 scolymus extract titrated fractions, or to title mixtures of said extract with one or more of said title fractions or mixtures of said fractions and to compositions and kits comprising them. comprise, for the prevention and / or treatment of a pathological condition characterized by a constitutive activation of the transcription factor of stat3.a presente invenção se refere a um extrato titulado de cynara scolymus, a frações tituladas de extrato de cynara 2/2 scolymus ou misturas tituladas do referido extrato com uma ou mais das referidas frações tituladas ou misturas das referidas frações e a composições e kits que os compreendem, para a prevenção e/ou tratamento de uma condição patológica caracterizada por uma ativação constitutiva do fator de transcrição de stat3.
